Soberlink - MAP Outcomes Study Protocol

Status Terminated

Clinical Trial Summary

The purpose of this study is to show the effectiveness of Soberlink's remote alcohol monitoring system integrated with MAP's patient engagement platform (EHR) to monitor a sample size of at-risk alcohol use disorder (AUD) population. Ultimately, this data is leveraged to improve clinical outcomes and manage financial risk through facilitating early interventions and other means of mitigating recidivism and costly treatment episodes from AUD population.

Clinical Trial Description

The study will include 30 Clients with a primary or secondary diagnosis of alcohol use disorder (AUD) and are enrolled in MAP's System where dedicated Case Managers are monitoring the Client's relapse risk levels. Soberlink's remote alcohol system will provide data to inform the Case Manager if the Client has relapsed or is at risk of relapsing through the use of testing data compiled by the Soberlink System. Integrating Soberlink results into MAP's EMR will allow Case Manager to make better clinical decisions and reduce costs by mitigating the chances recidivism through early intervention. Clients will use the Soberlink Device for a period of 90 days. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03190356
Study type	Observational
Source	Soberlink Healthcare LLC
Contact
Status	Terminated
Phase
Start date	August 22, 2017
Completion date	April 27, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04336293` - sTMS for Substance Use-disordered Veterans	N/A
Recruiting	`NCT01934751` - Effectiveness of a Hospital Addiction Service in Treating Opioid and Alcohol Addiction	N/A
Recruiting	`NCT03589118` - Qi Gong as a Method of Craving Reduction in Severe Addict Patients	N/A
Terminated	`NCT02374905` - Testing Interventions to Reduce Alcohol Consumption Among Outpatients in a Dental Setting	N/A
Recruiting	`NCT02643264` - Repetitive Transcranial Magnetic Stimulation (rTMS) of the Insula for Treatment of Alcohol Addiction	N/A
Not yet recruiting	`NCT01973127` - Transcranial Magnetic Stimulation in the Treatment of Addiction	N/A
Completed	`NCT03212599` - Disulfiram as a Modulator of Amyloid Precursor Protein-processing	N/A
Recruiting	`NCT05895643` - Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity?	Phase 2
Recruiting	`NCT03018236` - Effect of N-acetylcysteine on Alcohol and Cocaine Use Disorders: A Double-Blind Randomized Controlled Trial.	Phase 4
Terminated	`NCT02014779` - Internet-Based Relapse Prevention vs Face to Face Therapy at an Employee Assistance Program	N/A
Completed	`NCT02384304` - Guided and Unguided Internet Treatment for Problematic Alcohol Use	N/A
Completed	`NCT05093296` - Oxytocin and Naltrexone: Investigation of Combined Effects on Stress- and Alcohol Cue-induced Craving in Alcohol Use Disorder	Phase 2/Phase 3
Terminated	`NCT03854942` - Study of the Opioid Modulation of the Effect of Alcohol on the Dopaminergic Reward System	Phase 1